Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31274990 | 0.86 | ESR1 (0.58) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL216712 | 0.86 | ESR1 (0.58) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL40254 | 0.86 | ESR1 (0.58) | ESR1ESR2PDCD1CD274TDP1 | |
| Methane SCHEMBL7206625 | 0.83 | ESR1 (0.55) | ESR1ESR2PDCD1CD274TDP1 | |
| Hydroquinone SCHEMBL9580349 | 0.83 | LMNA (0.61) | ESR1ESR2ALDH1A1KMT2AALOX15 | |
| SCHEMBL22289400 | 0.81 | ESR1 (0.38) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL10445993 | 0.78 | ESR1 (0.65) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL4630558 | 0.78 | ESR1 (0.50) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL22694327 | 0.76 | IDO1 (0.56) | ESR1ESR2PDCD1CD274TDP1 | |
| SCHEMBL982047 | 0.76 | IDO1 (0.56) | ESR1ESR2PDCD1CD274TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12110306-B2 | Beta-hydroxyphosphonate functionalized polyols | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-10-08 | — | — | US | claimed |
| CN-113316598-B | Beta-hydroxy phosphonate functionalized polyols | 陶氏环球技术有限责任公司 | 2023-06-27 | — | — | CN | claimed |
| EP-3917983-B1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-02-01 | — | — | EP | claimed |
| US-20220119427-A1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-21 | — | — | US | claimed |
| EP-3917983-A2 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | Dow Global Technologies LLC (US) | 2021-12-08 | — | — | EP | claimed |
| CN-113316598-A | Beta-hydroxy phosphonate functionalized polyols | 陶氏环球技术有限责任公司 | 2021-08-27 | — | — | CN | claimed |
| WO-2020160094-A2 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-08-06 | — | — | WO | claimed |
| US-12110306-B2 | Beta-hydroxyphosphonate functionalized polyols | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-10-08 | — | — | US | disclosed |
| CN-113316598-B | Beta-hydroxy phosphonate functionalized polyols | 陶氏环球技术有限责任公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-3917983-B1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-02-01 | — | — | EP | disclosed |
| US-20220119427-A1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-21 | — | — | US | disclosed |
| EP-3917983-A2 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | Dow Global Technologies LLC (US) | 2021-12-08 | — | — | EP | disclosed |
| CN-113316598-A | Beta-hydroxy phosphonate functionalized polyols | 陶氏环球技术有限责任公司 | 2021-08-27 | — | — | CN | disclosed |
| WO-2020160094-A2 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12110306-B2 | Beta-hydroxyphosphonate functionalized polyols | IDH1, PHYKPL, IDH3B | ESR1 2295/4885ESR2 1888/4885PDCD1 4665/4885 |
| US-20220119427-A1 | BETA-HYDROXYPHOSPHONATE FUNCTIONALIZED POLYOLS | IDH1, PHYKPL, IDH3B | ESR1 2295/4885ESR2 1888/4885PDCD1 4665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.